Japan Biotech Firm OncoTherapy Science, Inc. Bid Only On Debut
10/19/2005 5:09:26 PM
Shares in biotechnology firm OncoTherapy Science Inc (Tokyo:4564.T - News) remained bid-only on their stock market debut on Monday, benefiting from small investors' appetite for initial public offering issues (IPOs).
The issue, the biggest IPO this year in Japan's start-up markets, was untraded due to a glut of bid orders at two million yen ($18,560) -- twice its issue price -- on the Tokyo Stock Exchange's Mothers market.
comments powered by